|
시장보고서
상품코드
2077923
알파 방출체 시장 : 방사성 핵종 종류별, 발생원별, 용도별, 최종사용자별, 지역별Alpha Emitter Market, by Type of Radionuclide (Radium, Actinium, Lead, Astatine-211, Bismuth-213 and Others), by Source (Natural Sources Artificially Produced Sources ), by Application, by End User and by Region, and By Geography |
||||||
알파 방출체 시장은 2026년에 17억 8,930만 달러 규모에 달할 것으로 추정되며, 2033년까지 35억 9,940만 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 10.5%로 성장할 것으로 전망됩니다.
| 분석 범위 | 분석 상세 | ||
|---|---|---|---|
| 기준 연도 | 2025년 | 시장 규모(2026년) | 17억 8,930만 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2026-2033년 |
| 예측 기간 CAGR(2026-2033년) | 10.50% | 예측 금액(2033년) | 35억 9,940만 달러 |
알파 입자는 2개의 양성자와 2개의 중성자가 견고하게 결합된 복합 입자입니다. 이들은 알파 붕괴라고 불리는 방사성 붕괴의 한 형태에서, 일부 방사성 핵종의 원자핵에서 방출됩니다. 알파 입자는 일반적인(원자량 4인) 헬륨 원자의 원자핵, 즉 이중 이온화된 헬륨 원자와 동일합니다. 알파 입자(알파선이라고도 함)는 최초로 발견된 핵방사선이며, 베타 입자와 감마선은 그 직후에 확인되었습니다. 알파 입자는 다른 종류의 핵방사선에 비해 속도가 비교적 느리고 질량도 큽니다. 이 입자는 빛의 속도의 5-7%, 즉 초당 2,000만 미터의 속도로 이동하며, 그 질량은 대략 양성자 4개에 해당합니다. 알파 입자는 높은 이온화 능력 때문에 물질을 깊숙이 투과할 수 없으며, 수 센티미터 두께의 공기층이나 10분의 1 밀리미터 미만의 생체 조직에 의해 그 운동이 멈추게 됩니다. 알파 입자가 높은 이온화 능력을 갖는 이유는, 두 개의 양전하와 베타 입자에 비해 큰 질량, 그리고 비교적 느린 속도 때문입니다. 알파 입자는 극히 짧은 거리 내에서 여러 차례의 이온화를 일으킬 수 있습니다. 따라서 동일한 양의 에너지가 방출될 경우, 알파 입자는 훨씬 더 큰 생물학적 손상을 일으킬 가능성이 있습니다. 알파 입자는 피부 바깥쪽에 있는 정상적인 사세포층을 관통할 수는 없지만, 눈의 각막에 손상을 줄 가능성이 있습니다. 알파 입자 방사선은 일반적으로 이미 체내나 세포 내에 있는 원자에서 방사성 붕괴가 일어날 때에만 안전상의 우려가 됩니다. 알파 입자를 방출하는 물질은 흡입되거나 섭취되거나, 혹은 상처를 통해 체내로 침투할 경우 특히 위험합니다.
시장 역학
주요 기업들은 치료용 방사성동위원소 생산 시설 확충에 주력하고 있으며, 이는 예측 기간 동안 전 세계 알파 방출체 시장에 매력적인 성장 기회를 가져다줄 것으로 예상됩니다. 예를 들어, 2023년 3월 1일, 제약 회사인 노스스타 메디컬 라디오아이소토프스(NorthStar Medical Radioisotopes)는 희귀한 치료용 방사성동위원소인 악티늄-225의 상업적 규모 생산 및 공급을 위한 노력에서 상당한 진전을 이뤘다고 발표했습니다. IBA사에서 특별 주문 제작한 'RhodotronTT 300-HE' 전자빔 가속기가 미국 위스콘신주 벨로이트에 위치한 NorthStar사의 새로운 Ac-225 생산 시설에 납품되어 건물 내에 설치되었습니다. NorthStar사의 확장 계획의 일환인 이 최첨단 시설은, 암 및 기타 중증 질환 환자 치료를 위한 Ac-225의 확장 가능하고 신뢰성이 높으며 환경 친화적인 생산을 보장하기 위해 비캐리어 첨가(n.c.a.) Ac-225의 제조에 전념하여 사용될 예정입니다.
본 보고서의 주요 특징
- 본 보고서는 각 부문의 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 시장의 촉진요인 및 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업들이 채택하는 경쟁 전략 등에 관한 중요한 인사이트도 제공하고 있습니다.
- 전 세계 알파 방출체 시장의 주요 기업 개요을 각종 지표(기업 개요, 제품 포트폴리오, 주요 동향, 재무 실적, 전략 등)를 바탕으로 수록하고 있습니다.
- 본 보고서의 인사이트를 바탕으로, 마케팅 담당자와 기업 경영진은 향후 제품 출시, 기술 업데이트, 시장 확대 및 마케팅 전략에 대해 충분한 정보를 바탕으로 의사결정을 내릴 수 있습니다.
- '세계 알파 방출체 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 재무 분석가 등 이 업계의 다양한 이해관계자들을 대상으로 합니다.
- 이해관계자들은 전 세계 알파 방출체 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 할 수 있습니다.
목차
제1장 분석 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 알파 방출체 시장 : 방사성 핵종 종류별(2021-2033년)
제5장 세계의 알파 방출체 시장 : 발생원별(2021-2033년)
제6장 세계의 알파 방출체 시장 : 용도별(2021-2033년)
제7장 세계의 알파 방출체 시장 : 최종사용자별(2021-2033년)
제8장 세계의 알파 방출체 시장 : 지역별(2021-2033년)
제9장 경쟁 구도
제10장 섹션
KSM 26.07.13Alpha Emitter Market is estimated to be valued at USD 1,789.3 Mn in 2026 and is expected to reach USD 3,599.4 Mn by 2033, growing at a compound annual growth rate (CAGR) of 10.5% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 1,789.3 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 10.50% | 2033 Value Projection: | USD 3,599.4 Mn |
Alpha particles are composite particles consisting of two protons and two neutrons tightly bound together. They are emitted from the nucleus of some radionuclides during a form of radioactive decay, called alpha-decay. An alpha-particle is identical to the nucleus of a normal (atomic mass four) helium atom i.e. a doubly ionized helium atom. Alpha particles (also termed alpha radiation or alpha rays) was the first nuclear radiation to be discovered, beta particles and gamma rays were identified soon after. Alpha particles are relatively slow and heavy compared with other forms of nuclear radiation. The particles travel at 5 to 7 % of the speed of light or 20,000,000 meters per second and has a mass approximately equivalent to 4 protons. Alpha particles, because they are highly ionizing, are unable to penetrate very far through matter and are brought to rest by a few centimeters of air or less than a tenth of a millimeter of biological tissue. Alpha particles are highly ionizing because of their double positive charge, large mass (compared to a beta particle) and because they are relatively slow. They can cause multiple ionizations within a very small distance. This gives them the potential to do much more biological damage for the same amount of deposited energy. Alpha particles cannot penetrate the normal layer of dead cells on the outside of our skin but can damage the cornea of the eye. Alpha-particle radiation is normally only a safety concern if the radioactive decay occurs from an atom that is already inside the body or a cell. Alpha-particle emitters are particularly dangerous if inhaled, ingested, or if they enter a wound.
Market Dynamics
Leading market players are focused on expanding their therapeutic radioisotope production facilities, which is expected to present attractive growth opportunities for global alpha emitter market, over the forecast period. For instance, on March 01, 2023, NorthStar Medical Radioisotopes, a pharmaceutical company, announced that it has made significant progress in its efforts to offer commercial-scale manufacturing of the rare therapeutic radioisotope actinium-225. A custom-built IBA RhodotronTT 300-HE electron beam accelerator has been delivered to NorthStar's new Ac-225 production facility in Beloit, Wisconsin, U.S. and installed in the building. This cutting-edge facility, which is a part of NorthStar's expansion plan, will be exclusively used to produce non-carrier added (n.c.a.) Ac-225, in order to ensure scalable, dependable, and environmentally preferable production of Ac-225 for the treatment of patients with cancer and other serious diseases.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global alpha emitter market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Actinium Pharmaceutical Inc., Alpha Tau Medical Ltd, Bayer AG, Bracco, Cardinal Health, Eckert & Ziegle, Fusion Pharmaceuticals, IBA Worldwide, NorthStar Medical Radioisotopes (NMR), Orano Group, Viewpoint Molecular Targeting, RadioMedix, Telix Pharmaceuticals Limited., TerraPower, LLC, NIOWAVE Inc. and IONETIX Corporation.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global alpha emitter market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global alpha emitter market
Detailed Segmentation:
- Global Alpha Emitter Market, By Type of Radionuclide (Revenue, USD Mn, 2021 - 2033)
- Radium (Ra-223)
- Actinium (Ac-225)
- Lead (Pb-212)
- Astatine-211
- Bismuth-213
- Others
- Global Alpha Emitter Market, By Source (Revenue, USD Mn, 2021 - 2033)
- Natural Sources
- Uranium-238
- Radium-226
- Artificially Produced Sources
- Plutonium
- Americium
- Curium
- Californium
- Global Alpha Emitter Market, By Application (Revenue, USD Mn, 2021 - 2033)
- Bone Metastases
- Prostate Cancer
- Neuroendocrine Tumors
- Ovarian Cancer
- Others
- Global Alpha Emitter Market, By End User (Revenue, USD Mn, 2021 - 2033)
- Hospitals
- Specialty Clinics
- Diagnostic Centers
- Others
- Global Alpha Emitter Market, By Region (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Actinium Pharmaceutical Inc.
- Alpha Tau Medical Ltd
- Bayer AG
- Bracco
- Cardinal Health
- Eckert & Ziegle
- Fusion Pharmaceuticals
- IBA Worldwide
- NorthStar Medical Radioisotopes (NMR)
- Orano Group
- Viewpoint Molecular Targeting
- RadioMedix
- Telix Pharmaceuticals Limited.
- TerraPower, LLC
- NIOWAVE Inc.
- IONETIX Corporation.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Type of Radionuclide
- Market Snapshot, By Source
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Recent Developments
- Acquisitions and Partnerships Scenario
- Technology Overview
- Regulatory Scenario
- PEST Analysis
4. Global Alpha Emitter Market, By Type of Radionuclide of Radionuclide, 2021 - 2033, (US$ Million)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Radium (Ra-223)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Actinium (Ac-225)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Lead (Pb-212)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Astatine-211
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Bismuth-213
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
5. Global Alpha Emitter Market, By Source, 2021 - 2033, (US$ Million)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Natural Sources
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Artificially Produced Sources
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
6. Global Alpha Emitter Market, By Application, 2021 - 2033, (US$ Million)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Bone Metastases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Prostate Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Neuroendocrine Tumors
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Ovarian Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
7. Global Alpha Emitter Market, By End User, 2021 - 2033, (US$ Million)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Speciality clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Diagnostic centers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
8. Global Alpha Emitter Market, By Region, 2021 - 2033, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Radionuclide, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Radionuclide, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Radionuclide, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
- U,K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Radionuclide, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Radionuclide, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Radionuclide, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (US$ Million)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Actinium Pharmaceutical Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Alpha Tau Medical Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Bayer AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Bracco
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Cardinal Health
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Eckert & Ziegle
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Fusion Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- IBA Worldwide
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- NorthStar Medical Radioisotopes (NMR)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Orano Group
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Viewpoint Molecular Targeting
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- RadioMedix
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Telix Pharmaceuticals Limited.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- TerraPower, LLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- NIOWAVE Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- IONETIX Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
10. Section
- Research Methodology
- About Us
